HRP20120682T1 - Protutumorski farmaceutski sastav koji sadr“i polipeptidne fragmente od seralizina - Google Patents
Protutumorski farmaceutski sastav koji sadr“i polipeptidne fragmente od seralizina Download PDFInfo
- Publication number
- HRP20120682T1 HRP20120682T1 HRP20120682TT HRP20120682T HRP20120682T1 HR P20120682 T1 HRP20120682 T1 HR P20120682T1 HR P20120682T T HRP20120682T T HR P20120682TT HR P20120682 T HRP20120682 T HR P20120682T HR P20120682 T1 HRP20120682 T1 HR P20120682T1
- Authority
- HR
- Croatia
- Prior art keywords
- seq
- fragments
- composition
- use according
- alone
- Prior art date
Links
- 239000012634 fragment Substances 0.000 title claims abstract 13
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract 4
- 108090000899 Serralysin Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000000259 anti-tumor effect Effects 0.000 claims abstract 5
- 230000001939 inductive effect Effects 0.000 claims abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 230000003449 preventive effect Effects 0.000 claims abstract 2
- 230000001225 therapeutic effect Effects 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims 9
- 230000001575 pathological effect Effects 0.000 claims 4
- 102000009465 Growth Factor Receptors Human genes 0.000 claims 2
- 108010009202 Growth Factor Receptors Proteins 0.000 claims 2
- 150000001720 carbohydrates Chemical class 0.000 claims 2
- 238000010353 genetic engineering Methods 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 230000002018 overexpression Effects 0.000 claims 2
- 230000002062 proliferating effect Effects 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 238000003786 synthesis reaction Methods 0.000 claims 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 230000001772 anti-angiogenic effect Effects 0.000 claims 1
- 230000001028 anti-proliverative effect Effects 0.000 claims 1
- 230000001640 apoptogenic effect Effects 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000037983 regulatory factors Human genes 0.000 claims 1
- 108091008025 regulatory factors Proteins 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/265—Enterobacter (G)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20040147A CU23475A1 (es) | 2004-07-08 | 2004-07-08 | Composición farmacéutica conteniendo fragmentos polipeptídicos de serralisinas |
| PCT/CU2005/000003 WO2006005268A2 (es) | 2004-07-08 | 2005-07-05 | Composición farmacéutica conteniendo fragmentos polipéptidicos de serralisinas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20120682T1 true HRP20120682T1 (hr) | 2012-09-30 |
Family
ID=40259088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20120682TT HRP20120682T1 (hr) | 2004-07-08 | 2012-08-27 | Protutumorski farmaceutski sastav koji sadr“i polipeptidne fragmente od seralizina |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8076297B2 (es) |
| EP (1) | EP1787653B1 (es) |
| JP (1) | JP4914350B2 (es) |
| KR (1) | KR101365056B1 (es) |
| AR (1) | AR050255A1 (es) |
| AU (1) | AU2005262159B2 (es) |
| BR (1) | BRPI0513136A (es) |
| CA (1) | CA2572984C (es) |
| CU (1) | CU23475A1 (es) |
| CY (1) | CY1114201T1 (es) |
| DK (1) | DK1787653T3 (es) |
| ES (1) | ES2389126T3 (es) |
| HR (1) | HRP20120682T1 (es) |
| MX (1) | MX2007000339A (es) |
| MY (1) | MY150858A (es) |
| PL (1) | PL1787653T3 (es) |
| PT (1) | PT1787653E (es) |
| RS (1) | RS52448B (es) |
| RU (1) | RU2396274C2 (es) |
| SI (1) | SI1787653T1 (es) |
| WO (1) | WO2006005268A2 (es) |
| ZA (1) | ZA200700178B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2378777T3 (es) * | 2004-11-23 | 2012-04-17 | Zymogenetics, Inc. | Purificación del factor XIII humano recombinante |
| JP5296051B2 (ja) | 2007-05-04 | 2013-09-25 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Ｍｒコイル吸収の補正を伴うハイブリッドｍｒ／ｐｅｔ |
| CU23950B1 (es) | 2011-03-21 | 2013-10-29 | Ct De Ingeniería Genética Y Biotecnología | Péptidos cíclicos con actividad antineoplásica y antiangiogénica |
| TWI746449B (zh) * | 2015-07-20 | 2021-11-21 | 美商Ａｉ治療公司 | 使用阿吡莫德治療癌症之方法 |
| CN109295041A (zh) * | 2018-10-10 | 2019-02-01 | 宁波希诺亚海洋生物科技有限公司 | 具有舍雷肽酶活性的多肽及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58134991A (ja) * | 1981-12-28 | 1983-08-11 | Takeda Chem Ind Ltd | セラチオペプチタ−ゼの安定化法 |
| JP2611206B2 (ja) * | 1985-11-15 | 1997-05-21 | 武田薬品工業株式会社 | 遺伝子およびその利用方法 |
| KR100252197B1 (ko) | 1997-09-20 | 2000-04-15 | 박호군 | 세라시아 마르세센스 균주의 배양액으로 부터 분리한 면역억제제용 프로디지오신 |
| US20040185566A1 (en) * | 2003-03-19 | 2004-09-23 | Peter Salamone | Polypeptides toxic to nematodes and methods of use |
-
2004
- 2004-07-08 CU CU20040147A patent/CU23475A1/es unknown
-
2005
- 2005-07-05 JP JP2007519599A patent/JP4914350B2/ja not_active Expired - Fee Related
- 2005-07-05 KR KR1020077002589A patent/KR101365056B1/ko active IP Right Grant
- 2005-07-05 CA CA2572984A patent/CA2572984C/en not_active Expired - Fee Related
- 2005-07-05 RU RU2007104776/13A patent/RU2396274C2/ru not_active IP Right Cessation
- 2005-07-05 WO PCT/CU2005/000003 patent/WO2006005268A2/es active Search and Examination
- 2005-07-05 EP EP05762122A patent/EP1787653B1/en active Active
- 2005-07-05 BR BRPI0513136-7A patent/BRPI0513136A/pt not_active Application Discontinuation
- 2005-07-05 PL PL05762122T patent/PL1787653T3/pl unknown
- 2005-07-05 AU AU2005262159A patent/AU2005262159B2/en not_active Ceased
- 2005-07-05 ES ES05762122T patent/ES2389126T3/es active Active
- 2005-07-05 US US11/631,880 patent/US8076297B2/en not_active Expired - Fee Related
- 2005-07-05 MX MX2007000339A patent/MX2007000339A/es active IP Right Grant
- 2005-07-05 RS RS20120391A patent/RS52448B/en unknown
- 2005-07-05 DK DK05762122.9T patent/DK1787653T3/da active
- 2005-07-05 SI SI200531578T patent/SI1787653T1/sl unknown
- 2005-07-05 PT PT05762122T patent/PT1787653E/pt unknown
- 2005-07-07 MY MYPI20053102 patent/MY150858A/en unknown
- 2005-07-08 AR ARP050102834A patent/AR050255A1/es active IP Right Grant
-
2007
- 2007-01-05 ZA ZA200700178A patent/ZA200700178B/xx unknown
-
2012
- 2012-08-27 HR HRP20120682TT patent/HRP20120682T1/hr unknown
- 2012-09-05 CY CY20121100800T patent/CY1114201T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CU23475A1 (es) | 2009-12-17 |
| CY1114201T1 (el) | 2016-08-31 |
| DK1787653T3 (da) | 2012-09-17 |
| US8076297B2 (en) | 2011-12-13 |
| SI1787653T1 (sl) | 2012-10-30 |
| US20110218138A1 (en) | 2011-09-08 |
| ES2389126T3 (es) | 2012-10-23 |
| PT1787653E (pt) | 2012-09-06 |
| BRPI0513136A (pt) | 2008-04-29 |
| CA2572984C (en) | 2014-12-09 |
| EP1787653A2 (en) | 2007-05-23 |
| MX2007000339A (es) | 2007-03-12 |
| JP4914350B2 (ja) | 2012-04-11 |
| WO2006005268A2 (es) | 2006-01-19 |
| PL1787653T3 (pl) | 2012-11-30 |
| MY150858A (en) | 2014-03-14 |
| KR101365056B1 (ko) | 2014-02-21 |
| KR20070042542A (ko) | 2007-04-23 |
| AR050255A1 (es) | 2006-10-11 |
| AU2005262159A1 (en) | 2006-01-19 |
| RU2396274C2 (ru) | 2010-08-10 |
| RS52448B (en) | 2013-02-28 |
| WO2006005268A3 (es) | 2006-03-09 |
| ZA200700178B (en) | 2008-06-25 |
| AU2005262159B2 (en) | 2011-08-18 |
| CA2572984A1 (en) | 2006-01-19 |
| RU2007104776A (ru) | 2008-08-20 |
| JP2008505129A (ja) | 2008-02-21 |
| EP1787653B1 (en) | 2012-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Passalacqua et al. | Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation | |
| HRP20120682T1 (hr) | Protutumorski farmaceutski sastav koji sadr“i polipeptidne fragmente od seralizina | |
| Li et al. | Bioactive silicate materials stimulate angiogenesis in fibroblast and endothelial cell co-culture system through paracrine effect | |
| Ferrara et al. | Bovine brain astrocytes express basic fibroblast growth factor, a neurotropic and angiogenic mitogen | |
| Nakaji-Hirabayashi et al. | Hyaluronic acid hydrogel loaded with genetically-engineered brain-derived neurotrophic factor as a neural cell carrier | |
| Masuda-Murakami et al. | Effects of mineral trioxide aggregate on the differentiation of rat dental pulp cells | |
| Hosseini et al. | Contribution of osteocalcin-mimetic peptide enhances osteogenic activity and extracellular matrix mineralization of human osteoblast-like cells | |
| ATE511857T1 (de) | Anti-april monoklonaler antikörper und deren verwendung zur behandlung von immunerkrankungen oder krebs | |
| JP2009524425A (ja) | 脂肪由来幹細胞を利用した成長因子の大量生産方法 | |
| JP2011140495A (ja) | Ｄｎａ結合タンパク質の使用 | |
| Souza et al. | Regeneration of skin tissue promoted by mesenchymal stem cells seeded in nanostructured membrane | |
| Adamsky et al. | Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase β (RPTPβ) to tenascin C | |
| US20100112031A1 (en) | Compositions And Methods For Regulating Extracellular Matrix Production In Adipose Derived Cells | |
| EP3587440B1 (en) | Human pd-l1 high-protein-affinity peptide and use thereof | |
| You et al. | The effects of cerium valence states at cerium oxide coatings on the responses of bone mesenchymal stem cells and macrophages | |
| SK7012003A3 (en) | Fibroblast growth factors | |
| Wang et al. | Osteogenic differentiation of amniotic epithelial cells: synergism of pulsed electromagnetic field and biochemical stimuli | |
| Mehta et al. | Amelioration of collagen antibody induced arthritis in mice by an antibody directed against the fibronectin type III repeats of tenascin-C: Targeting fibronectin type III repeats of tenascin-C in rheumatoid arthritis | |
| Nakaji-Hirabayashi et al. | Surface-anchoring of spontaneously dimerized epidermal growth factor for highly selective expansion of neural stem cells | |
| KR20140030396A (ko) | 엘라스틴 유사 단백질 및 그 제조방법, 이를 이용한 신경세포의 분화방법 | |
| Gray et al. | Measurement of antibodies to collagen II by inhibition of collagen fibril formation in vitro | |
| Huang et al. | Neuron localization and neuroblastoma cell expression of brain-derived growth factor | |
| CN112679615B (zh) | 一种融合蛋白 | |
| Masuda et al. | Laminin peptide YIGSR and its receptor regulate sensory axonal response to the chemoattractive guidance cue in the chick embryo | |
| Jiang et al. | In vitro guidance of retinal axons by a tectal lamina-specific glycoprotein Nel |